NAMS vs PHAR: Side-by-Side Comparison
Compare NewAmsterdam Pharma Company NV (NAMS) and Pharming Group N.V. (PHAR) side by side: market cap USD 4.07B vs USD 965.83M. Financials, growth and model signals on Bullrun.
| Metric | NAMS | PHAR |
|---|---|---|
| Company | NewAmsterdam Pharma Company NV | Pharming Group N.V. |
| Country / Exchange | Netherlands · NASDAQ | Netherlands · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 4.07B | USD 965.83M |
| P/E ratio | — | 79.9 |
| Dividend yield | — | — |
| Valuation model | — | 37.6% overvalued |
| Revenue (latest FY) | USD 22.50M | — |
| Revenue growth YoY | -50.6% | — |
| Net income | USD -203.00M | — |
| Gross margin | — | — |
| Diluted EPS | -1.72 | — |